FOR EDITORIAL COMMENT, SEE PAGE 583Pneumonia continues to be a major cause of morbidity and mortality in adults, accounting for approximately 55,000 deaths, 1.2 million hospitalizations, and 1.7 million ED visits annually in the United States.[@bib1], [@bib2], [@bib3] The diagnosis of pneumonia is based on clinical features plus radiological findings consistent with pulmonary infection.[@bib4] Traditionally, chest radiography has been the primary radiographic test used to evaluate for community-acquired pneumonia (CAP).[@bib4] However, the use of chest CT imaging to evaluate patients with acute respiratory symptoms has markedly increased during the past 2 decades as clinical practice has evolved to more commonly assess for noninfectious conditions, such as pulmonary embolism and aortic dissection, and to more thoroughly image the lungs for signs of pneumonia.[@bib5], [@bib6] CT imaging is more sensitive than chest radiography for identifying radiological signs of pneumonia, resulting in some patients having pneumonia visualized on CT scans but not on concurrent chest radiographs (CT-only pneumonia).[@bib7], [@bib8], [@bib9], [@bib10], [@bib11]

The clinical significance of radiological signs of pneumonia visualized only on CT imaging is largely unknown, creating uncertainty about whether these patients should be managed according to the same principles as those with pneumonia identified on chest radiography or whether CT-only pneumonia is a distinct, less severe disease.[@bib12] The purpose of this study was to compare the pathogens detected, illness severity, and clinical outcomes in patients with CT-only pneumonia and those with pneumonia visualized on chest radiography among adults hospitalized with CAP.

Methods {#sec1}
=======

This analysis was nested within the Centers for Disease Control and Prevention (CDC) Etiology of Pneumonia in the Community (EPIC) study, a multicenter prospective active surveillance study of patients hospitalized with CAP.[@bib13] Adults were enrolled from January 1, 2010 to June 30, 2012 at five hospitals, including three in Chicago, Illinois and two in Nashville, Tennessee. Institutional review boards at the CDC and each enrolling hospital approved the study (Vanderbilt University IRB No. 091422). Informed consent for study participation was obtained from all enrolled patients or their representatives.

Study Population {#sec1.1}
----------------

The EPIC study population of adults hospitalized with CAP has been previously described.[@bib13] In brief, adults (≥ 18 years old) were eligible if they were admitted to a study hospital, lived in a study catchment area surrounding each participating hospital, and had clinical evidence of an acute respiratory infection and radiological signs of pneumonia as interpreted by a study-dedicated thoracic radiologist. Exclusion criteria included patients with a recent hospitalization (within the previous 28 days for immunocompetent patients and within 90 days for immunosuppressed patients), nursing home residents who were not functionally independent, patients who had undergone tracheostomy or gastrostomy, patients with cystic fibrosis, cancer with neutropenia, solid organ or hematopoietic stem cell transplantation within the previous 90 days, active graft-vs-host disease, bronchiolitis obliterans, HIV infection with a CD4 cell count \< 200 mm^3^, and those with a nonpneumonia alternative diagnosis for the cause of acute respiratory symptoms. The study population for the current analysis included adults in the EPIC study who had adequate etiology testing (one test or more for bacteria and one test or more for viruses) and a chest radiograph obtained within 48 hours of enrollment.

Radiological Evidence of Pneumonia {#sec1.2}
----------------------------------

Inclusion in the EPIC study required a chest radiograph or CT scan within 48 hours before or after hospital admission demonstrating signs of pneumonia.[@bib13] The choice of chest imaging (ie, whether to obtain a chest CT scan in addition to or in lieu of a chest radiograph) was made by the treating clinician independent of the study protocol. Initially, patients were enrolled based on interpretation of chest imaging as consistent with acute pneumonia by the clinicians or radiologists interpreting images for routine clinical care. Subsequently, all chest radiographs and CT scans obtained within 48 hours of admission were independently reviewed by a board-certified, study-dedicated thoracic radiologist blinded to the clinical data. The study included two thoracic radiologists (E. M. H. and F. C.), with one reading images from the three Chicago hospitals and the other reading images from the two Nashville hospitals. These radiologists used the same protocol and data collection form when interpreting images and recording their findings. Available chest imaging prior to the current hospitalization was used to help distinguish between acute and chronic findings.

Only patients with radiological evidence of pneumonia on chest radiography or CT imaging, or both, as interpreted by the study-dedicated radiologists were included in the final EPIC study population. Patients were classified as having chest radiographic evidence of pneumonia if the radiologist identified a new consolidation (dense or fluffy opacity with or without air bronchograms), other infiltrate (linear or patchy alveolar or interstitial densities), or pleural effusion on any chest radiograph completed within 48 hours of hospital presentation.[@bib13], [@bib14] When interpreting CT scans, radiologists noted their global impression of whether the images were consistent with acute pneumonia by selecting one of four options: (1) no pneumonia, (2) possible pneumonia, (3) probable pneumonia, or (4) definite pneumonia. Patients were classified as having CT scan evidence of pneumonia if the radiologist indicated possible, probable, or definite pneumonia.

Study Groups for Comparison {#sec1.3}
---------------------------

Patients with evidence of pneumonia on CT scan but not chest radiograph were classified as having *CT-only pneumonia*. Patients with chest radiograph evidence of pneumonia were classified as having *pneumonia on chest radiography* regardless of whether CT scan imaging was completed. Patients who were included in the EPIC study based on CT findings without a chest radiograph completed within 48 hours of admission were excluded from the current analysis, because the goal was to evaluate patients with pneumonia visualized on CT imaging but not on concurrent chest radiography.

The primary analysis involved a comparison between patients with CT-only pneumonia and those with pneumonia on chest radiography. In secondary analyses, which are reported in [e-Tables 1-8](#appsec1){ref-type="sec"}, the pneumonia on chest radiography group was divided into three subcategories---pneumonia on chest radiography/CT imaging not performed; pneumonia on chest radiography/CT pneumonia; and pneumonia on chest radiography/no pneumonia on CT scan.

Outcomes {#sec1.4}
--------

Patients with CT-only pneumonia and pneumonia on chest radiography were compared based on three categories: initial clinical characteristics and antibiotics received, pathogens detected, and short-term clinical outcomes.

### Initial clinical characteristics and antibiotics {#sec1.4.1}

Patient characteristics were systematically ascertained through patient interview and medical record abstraction.[@bib13] Obesity was defined as a BMI ≥ 30 kg/m^2^.[@bib15] Pneumonia severity scores, including the Pneumonia Severity Index,[@bib16] CURB-65 (confusion, urea nitrogen, respiratory rate, blood pressure, 65 years of age and older),[@bib17] and American Thoracic Society Minor Criteria for Severe CAP,[@bib4] were calculated to summarize each patient's condition at the time of initial hospital presentation. Patients with residual serum collected at hospital presentation also had serum procalcitonin (PCT) measured for research purposes using the VIDAS BRAHMS PCT immunoassay kit (BioMerieux, Inc.).[@bib18], [@bib19] The lower limit of detection for this assay was 0.05 ng/mL. PCT results were not available to clinicians and were not used for patient management. Prior research suggests a PCT threshold of 0.25 ng/mL can help distinguish between viral and bacterial infection[@bib20], [@bib21]; therefore, PCT was analyzed on a continuous scale and also dichotomized as \< 0.25 ng/mL (low) vs ≥ 0.25 ng/mL (high). We also reported the proportion of patients who received antibiotics within 6 and 12 hours of hospital presentation and the specific antibiotics used for initial empirical treatment, defined as antibiotics delivered on the first day of hospitalization, including those given in the ED.

### Pathogens {#sec1.4.2}

Biological specimens for pathogen detection were systematically collected from each patient as soon as possible after hospital presentation.[@bib13] Viral testing as part of the study protocol included real-time polymerase chain reaction (RT-PCR) of nasopharyngeal/oropharyngeal swabs and paired acute and convalescent serologic tests for respiratory viruses, including adenovirus, coronaviruses (RT-PCR only), human metapneumovirus, human rhinovirus (RT-PCR only), influenza, parainfluenza, and respiratory syncytial virus.[@bib22], [@bib23], [@bib24], [@bib25] Bacterial testing as part of the study protocol included blood cultures, sputum cultures (limited to high-quality samples[@bib26]), urinary antigen tests for *Streptococcus pneumoniae* and *Legionella pneumophila,* [@bib27], [@bib28] RT-PCR of nasopharyngeal/oropharyngeal swabs for *Chlamydophila pneumoniae* and *Mycoplasma pneumoniae* and of sputum for *Legionella*.[@bib29] Other respiratory samples, including endotracheal aspirates, pleural fluid, and BAL, obtained for routine clinical care also underwent bacterial culture.

### Clinical outcomes {#sec1.4.3}

Clinical outcomes during the index hospitalization were ascertained by medical record abstraction.[@bib13] These outcomes included hospital length-of-stay, ICU admission, invasive mechanical ventilation, vasopressor-dependent septic shock, moderate or severe ARDS, and inhospital mortality. Invasive mechanical ventilation was defined as new assisted ventilation through an endotracheal tube or tracheostomy. Vasopressor-dependent septic shock was defined as vasopressor administration by continuous infusion at any time during the first 72 hours of the hospitalization for pneumonia. Moderate or severe ARDS was defined as meeting all the following criteria within 72 hours of hospitalization: bilateral pulmonary opacities, Pa[o]{.smallcaps} ~2~/F[io]{.smallcaps} ~2~ \< 200 mm Hg, and respiratory failure not fully explained by cardiac failure.[@bib30]

Statistical Analysis {#sec1.5}
--------------------

Outcomes were compared between patients with CT-only pneumonia and those with pneumonia on chest radiograph with the Wilcoxon rank-sum test for continuous variables and the χ^2^ or Fisher exact test for categorical variables, as appropriate. Analyses were performed with Stata, version 12.1; (StataCorp LLC).

Results {#sec2}
=======

Study Population {#sec2.1}
----------------

During the 2½-year study period, 3,634 eligible patients were identified through prospective active surveillance; 2,251 of these patients (62%) were enrolled, had radiological pneumonia confirmed by a study radiologist, underwent adequate testing for the cause of pneumonia, and had chest radiography performed (study population for the current analysis) ([Fig 1](#fig1){ref-type="fig"} ). All 2,251 included patients underwent chest radiography, and 748 (33%) had concurrent CT imaging. Compared with patients who did not undergo CT imaging, those with a CT scan had similar vital signs but fewer comorbidities, were more likely to present with hemoptysis, shortness of breath, and chest pain, and had somewhat lower pneumonia severity scores ([e-Tables 1-3](#appsec1){ref-type="sec"}).Figure 1Flow diagram for generation of the study population.

Sixty-six (3%) of the 2,251 included patients had CT-only pneumonia. All 66 of these patients had CT imaging within 1 calendar day of undergoing chest radiography that showed no signs of pneumonia, including 43 patients (65%) with CT imaging and chest radiography on the same day and 23 patients (35%) with CT imaging completed 1 calendar day later than chest radiography. Among the 66 cases of CT-only pneumonia, the radiologist interpreted CT images as definite pneumonia in 34 patients (52%), probable pneumonia in 14 patients (21%), and possible pneumonia in 18 (27%) patients.

Of the 2,251 included patients, 2,185 (97%) had pneumonia on chest radiography. Among those with pneumonia on chest radiography, 1,503 (69%) did not have a concurrent CT scan, 652 (30%) had pneumonia confirmed on CT scan, and 30 (1%) had a CT scan without evidence of pneumonia ([e-Tables 4-6](#appsec1){ref-type="sec"}).

Initial Clinical Characteristics and Antibiotics {#sec2.2}
------------------------------------------------

Overall, the presenting clinical profiles of patients with CT-only pneumonia and pneumonia on chest radiography were similar, including comorbidities, vital signs, and laboratory test results ([Table 1](#tbl1){ref-type="table"} ). However, compared with the pneumonia on chest radiography patients, the patients with CT-only pneumonia were younger and more likely to present with chest pain, wheezing, and low-risk Pneumonia Severity Index categories I and II. BMI was also higher in the CT-only pneumonia group (median, 30 kg/m^2^) compared with the pneumonia on chest radiography group (median, 27 kg/m^2^; *P* = .02), thus leading to a higher proportion of patients in the CT-only pneumonia group meeting the definition for obesity (49% vs 36%; *P* = .04). Serum PCT concentrations were lower in the CT-only pneumonia group (median, \< 0.05 ng/mL; interquartile range \[IQR\], \< 0.05-0.11 ng/mL) compared with the pneumonia on chest radiography group (median, 0.16 ng/mL; IQR, \< 0.05-0.85 ng/mL); 18% of the patients with CT-only pneumonia had a PCT level \> 0.25 ng/mL compared with 41% of the patients with pneumonia on chest radiography (*P* \< .01).Table 1Clinical Characteristics at Hospital PresentationVariableCT-Only Pneumonia (n = 66)Pneumonia on Chest Radiography (n = 2,185)*P* ValueDemographics Age, median (IQR), y53 (40-63)58 (47-71)\< .01 Female sex, No. (%)39 (59.1)1,111 (50.9).18Vital signs, median (IQR) Heart rate, beats/min100 (88-118)100 (87-114).51 Systolic blood pressure, mm Hg140 (126-157)131 (114-148)\< .01 Respiratory rate, breaths/min20 (18-24)20 (18-24).62 Temperature, °C36.9 (36.3-37.9)36.9 (36.2-37.8).73 Oxygen saturation, %96 (94-98)95 (92-97).07Signs and symptoms, No. (%) Cough with sputum production39 (59.1)1,206 (55.2).53 Hemoptysis5 (7.6)192 (8.8).73 Shortness of breath49 (74.2)1,703 (77.9).48 Chest pain44 (66.7)1,065 (48.7)\< .01 Confusion11 (16.7)438 (20.1).50 Wheezing37 (56.1)937 (42.9).03Comorbidities, No. (%) Asthma21 (31.8)561 (25.7).26 COPD14 (21.2)505 (23.1).72 Chronic heart failure8 (12.1)422 (19.3).14 Diabetes mellitus21 (31.9)563 (25.8).27 Chronic kidney disease9 (13.6)344 (15.7).64 Chronic liver disease3 (4.6)122 (5.6).72 Obesity (BMI ≥ 30 kg/m^2^)32 (48.5)789 (36.1).04 Current tobacco smoker17 (25.8)577 (26.4).91Laboratory values, median (IQR) WBC count, cells/μL11,050 (6,900-14,200)11,400 (8,000-14,900).13 Blood urea nitrogen, mg/dL12 (9-19)15 (10-24)\< .01 Blood glucose, mg/dL120 (102-144)115 (99-145).46 Procalcitonin, ng/mL[a](#tbl1fna){ref-type="table-fn"}\< 0.05 (\<0.05-0.11)0.16 (\< 0.05-0.85)\< .01Pneumonia severity Index risk class, No. (%) I-II (low risk)41 (62.1)979 (44.8).02 III (moderate risk)11 (16.7)439 (20.1) IV-V (high risk)14 (21.2)767 (35.1)CURB-65 score, No. (%) 0-1 (low risk)53 (80.3)1,517 (69.4).14 2 (moderate risk)7 (10.6)422 (19.3) 3-5 (high risk)6 (9.1)246 (11.3)ATS severe pneumonia criteria, No. (%) \< 3 criteria (not severe)63 (95.5)2,028 (92.8).62 ≥ 3 criteria (severe)3 (4.5)157 (7.2)[^1][^2]

A smaller proportion of patients with CT-only pneumonia received antibiotics within 6 hours of hospital presentation than did those with pneumonia on chest radiography (59% vs 83%; *P* \< .01), but results were similar by 24 hours (97% vs 96%; *P* = .80) ([e-Table 7](#appsec1){ref-type="sec"}). Specific antibiotic regimens were quite similar for patients with CT-only pneumonia and those with pneumonia on chest radiography, with ß-lactam plus macrolide and fluoroquinolone monotherapy regimens the most common in both groups ([Table 2](#tbl2){ref-type="table"} ).Table 2Antibiotics Administered on the First Day of HospitalizationAntibiotic Regimen on Hospital Day 1CT-Only Pneumonia (n = 66) No. (%)Pneumonia on Chest Radiography (n = 2,185) No. (%)ß-lactam + macrolide12 (18.2)488 (22.3)Respiratory fluoroquinolone[a](#tbl2fna){ref-type="table-fn"} alone12 (18.2)470 (21.5)Respiratory fluoroquinolone[a](#tbl2fna){ref-type="table-fn"} + ß-lactam6 (9.1)113 (5.2)ß-lactam + macrolide + glycopeptide5 (7.6)151 (6.9)Respiratory fluoroquinolone[a](#tbl2fna){ref-type="table-fn"} + ß-lactam + macrolide3 (4.6)202 (9.2)Respiratory fluoroquinolone[a](#tbl2fna){ref-type="table-fn"} + ß-lactam + glycopeptide3 (4.6)92 (4.2)ß-lactam alone2 (3.0)65 (3.0)Respiratory fluoroquinolone[a](#tbl2fna){ref-type="table-fn"} + ß-lactam + macrolide + glycopeptide2 (3.0)52 (2.4)ß-lactam + glycopeptide2 (3.0)50 (2.3)Respiratory fluoroquinolone[a](#tbl2fna){ref-type="table-fn"} + macrolide1 (1.5)42 (1.9)Respiratory fluoroquinolone[a](#tbl2fna){ref-type="table-fn"} + glycopeptide2 (3.0)32 (1.5)Macrolide alone3 (4.6)22 (1.0)Respiratory fluoroquinolone[a](#tbl2fna){ref-type="table-fn"} + macrolide + glycopeptide0 (0)5 (0.2)Glycopeptide alone1 (1.5)2 (0.1)Other regimens11 (16.7)349 (16.0)[^3]

Pathogens {#sec2.3}
---------

Pathogen detection was similar in the CT-only pneumonia group and the pneumonia on chest radiography group, with viruses being more commonly detected than bacteria in both groups ([Table 3](#tbl3){ref-type="table"} ). The prevalence of major CAP pathogens, including *S pneumoniae, M pneumoniae, Staphylococcus aureus*, and influenza, were also similar between groups. However, the detection of human rhinovirus was more common in the CT-only pneumonia group than in the pneumonia on chest radiography group (17% vs 8%; *P* = .02). Interestingly, two of the eight patients in the CT-only pneumonia group with bacterial pathogens detected had PCT \< 0.25 ng/mL. Both of these patients had *S. pneumoniae* detected by a urinary antigen test ([e-Table 8](#appsec1){ref-type="sec"}).Table 3Pathogens DetectedPathogens Detected, No. (%)CT-Only Pneumonia (n = 66)Pneumonia on Chest Radiography (n = 2,185)*P* ValueAny pathogen27 (40.9)822 (37.6).59Codetection of ≥ 1 pathogen2 (3.0)108 (4.9).48Any bacteria8 (12.1)297 (13.6).86 *Streptococcus pneumoniae*3 (4.6)111 (5.1).00 Group A streptococcus0 (0)7 (0.32).65 Viridans group streptococci0 (0)8 (0.37).62 Other streptococcal species0 (0)8 (0.4).62 *Staphylococcus aureus*0 (0)37 (1.7).63 *Haemophilus influenzae*0 (0)13 (0.6).00 *Escherichia coli*1 (1.5)16 (0.7).47 *Pseudomonas aeruginosa*1 (1.5)7 (0.3).11 *Klebsiella pneumoniae*2 (3.0)10 (0.5).01 *Mycoplasma pneumoniae*0 (0)43 (2.0).64 *Chlamydia pneumoniae*1 (1.5)8 (0.4).24 *Legionella pneumophila*0 (0)32 (1.5).62 Other bacteria[a](#tbl3fna){ref-type="table-fn"}09 (0.4).60Any virus20 (30.3)570 (26.1).44 Influenza4 (6.1)126 (5.8).92 Parainfluenza virus1 (1.5)66 (3.0).72 Coronavirus0 (0)53 (2.4).41 Human metapneumovirus4 (6.1)84 (3.8).36 Respiratory syncytial virus0 (0)68 (3.1).26 Human rhinovirus11 (16.7)182 (8.3).02 Adenovirus1 (1.5)31 (1.4).62[^4]

Clinical Outcomes {#sec2.4}
-----------------

Clinical outcomes, including hospital length of stay, ICU admission, mechanical ventilation, and shock, were similar between patients with CT-only pneumonia and patients with pneumonia on chest radiography ([Table 4](#tbl4){ref-type="table"} ). Inhospital death was rare in both the CT-only and pneumonia on chest radiography groups (0% vs 2%).Table 4Clinical OutcomesClinical OutcomeCT-Only Pneumonia (n = 66)Pneumonia on Chest Radiography (n = 2,185)*P* ValueIn-hospital death, No. (%)0 (0)49 (2.2).40Hospital length-of-stay among survivors, median (IQR), d3.5 (2-5)3 (2-6).90ICU admission, No. (%)15 (22.7)467 (21.4).80Invasive mechanical ventilation, No. (%)4 (6.1)113 (5.2).76Vasopressor-dependent septic shock, No. (%)3 (4.6)84 (3.8).74Moderate-severe ARDS, No. (%)1 (1.5)89 (4.1).52[^5]

Description of Patients With Pneumonia on Chest Radiography and No Pneumonia on CT Scan {#sec2.5}
---------------------------------------------------------------------------------------

Thirty patients (1.3% of the full study population and 4.0% of patients who had CT imaging completed) had a chest radiograph interpreted as consistent with pneumonia and a CT scan interpreted as not consistent with pneumonia. Nonpneumonia abnormalities were identified on CT scans in each of these patients that explained why a chest radiograph may have been interpreted as consistent with pneumonia; these findings included lymphadenopathy (13 cases), pulmonary edema (five cases), atelectasis (three cases), pulmonary fibrosis (three cases), emphysema (three cases), pulmonary infarct (two cases), and postsurgical changes (one patient).

Compared with the 652 patients who had both a chest radiograph and CT scan interpreted as pneumonia, these 30 patients with pneumonia on chest radiography and no pneumonia on CT imaging were older, were more likely to have asthma or COPD, and had lower WBC counts (median, 8,900 vs 11,300 cells/μL) and lower PCT concentrations (median, \< 0.05 vs 0.15 ng/mL) ([e-Table 2](#appsec1){ref-type="sec"}). Bacterial pathogens and severe infection-related outcomes were rare in these 30 patients with pneumonia on chest radiography but no pneumonia on CT imaging. Only four of these patients (13.3%) had a pathogen detected, including two with parainfluenza virus, one with rhinovirus, and one with *Fusobacterium necrophorum* ([e-Table 5](#appsec1){ref-type="sec"}). The patient with *F necrophorum* bacteremia presented with a 2-day history of sore throat and was found to have a pulmonary infarct on CT scanning, suggestive of Lemierre's syndrome (bacterial pharyngitis, usually caused by *F necrophorum,* associated thrombophlebitis of the internal jugular vein)[@bib31]; this patient recovered with antibiotic treatment and was discharged. None of these 30 patients with pneumonia on chest radiography but no pneumonia on CT scanning had respiratory failure, septic shock, or ARDS ([e-Table 4](#appsec1){ref-type="sec"}). One of these patients died---a patient with advanced liver disease and metastatic hepatocellular carcinoma who had a pulmonary infarct visualized on CT imaging.

Discussion {#sec3}
==========

In this cohort of 2,251 adults hospitalized with CAP, 66 had radiological evidence of pneumonia on CT imaging but not on concurrent chest radiography. Detailed evaluation of these 66 patients with CT-only pneumonia revealed illness severity, pathogens, and clinical outcomes similar to those of patients with pneumonia evident on chest radiography. These findings support managing patients with CT-only pneumonia according to the same principles used for those with pneumonia on chest radiography, including the selection of empirical antibiotics and site of care. Additionally, these results suggest that pneumonia that is visible only on CT scan can be associated with significant physiological abnormalities and morbidity, and hence, support using CT imaging to evaluate for pneumonia when the clinical presentation is suggestive of pneumonia but an initial chest radiograph does not demonstrate radiological signs of pneumonia and identification of pneumonia as the cause of clinical symptoms is important. Examples of such a scenario may include patients with septic shock or fever with altered mental status but no clear source of infection after initial evaluation with a history, physical examination, laboratory work, and chest radiography.[@bib32], [@bib33], [@bib34]

Currently, nearly all adults hospitalized with CAP in the United States are treated with antibiotics.[@bib13] However, only a minority of these patients have detectable bacterial pathogens.[@bib13] Hence, many antibiotic stewardship strategies are under development to identify patients who historically have been treated with antibiotics but are unlikely to benefit from them.[@bib20], [@bib35] Our results suggest that stewardship strategies are also needed for CT-only pneumonia. We found that 12% of patients with CT-only pneumonia had a bacterial pathogen; this prevalence is too high to recommend withholding antibiotics for all patients with CT-only pneumonia. However, similar to pneumonia on chest radiography, a substantial portion of patients with CT-only pneumonia appear to have nonbacterial disease. Although more research in this area is needed, stewardship strategies developed for pneumonia on chest radiography, such as PCT-based algorithms for guiding antibiotic prescribing,[@bib20] may also be useful for CT-only pneumonia.

Although patients with CT-only pneumonia and patients with pneumonia on chest radiography were largely similar, our analysis identified some potential differences that will be important to explore in future studies. For example, CT-only pneumonia appeared to be more common in obese patients, perhaps due to lower chest radiography sensitivity associated with x-ray beam attenuation by adipose tissues in obese patients.[@bib36], [@bib37] Also, patients with CT-only pneumonia as a group appeared to have lower PCT levels and a higher prevalence of human rhinovirus detection, suggesting that viral pathogens may be more common in CT-only pneumonia than in pneumonia seen on chest radiography. However, it is important to note that 12% of patients with CT-only pneumonia had a bacterial pathogen detected, which was similar to the incidence observed in the pneumonia on chest radiography group. Additionally, two patients with CT-only pneumonia and a serum PCT concentration \< 0.25 ng/mL had pneumococcal infection, highlighting that the combination of chest radiography and PCT determination does not identify all bacterial pneumonia.

Claessens et al[@bib7] recently published a study evaluating the effect of routine CT scan use for patients with suspected CAP in the ED. While we focused on identifying the pathogens and clinical outcomes of patients with CT-only pneumonia, Claessens et al[@bib7] focused on understanding how CT scans performed in patients with suspected pneumonia changed clinical management. Among the 308 patients with clinically suspected pneumonia in the Claessens et al study, 40 (13%) had CT-only pneumonia, and clinicians typically responded to a positive CT scan for pneumonia after a normal chest radiograph by administering antibiotics. Our results complement those of Claessens et al by suggesting that the pathogens and clinical outcomes associated with CT-only pneumonia do indeed warrant consideration for antibiotic therapy. Claessens et al[@bib7] also found that 18% of patients in their study had a chest radiograph suggestive of pneumonia but a CT scan without evidence of pneumonia, and clinicians were likely to discontinue antibiotics and change the disposition from inpatient to outpatient based on results of the CT scan demonstrating no pneumonia. Our data also support a clinical decision to use normal CT scans to de-escalate care based on a chest radiograph suggestive of pneumonia. In our study, only one of 30 patients with a chest radiograph suggestive of pneumonia and a CT scan without evidence of pneumonia had a bacterial pathogen detected, and CT images often clarified the abnormality seen on chest radiograph as a nonpneumonia finding.

There were limitations to our study. First, the use of CT imaging was determined by treating clinicians independent of the study protocol; clinicians elected to perform CT imaging in approximately one-third of the patients in the cohort. As noted in [e-Table 1](#appsec1){ref-type="sec"}, patients with chest pain, shortness of breath, and hemoptysis were more likely to undergo CT imaging, likely due to clinicians' concerns for pulmonary embolism or cancer in patients with these symptoms; therefore, study results may not be generalizable to patients whose clinicians are not concerned enough to order chest CT imaging. Second, because radiological evidence of pneumonia on chest radiography or CT scanning was required for cohort inclusion, we did not evaluate patients with clinically suspected pneumonia who had a chest radiograph without evidence of pneumonia and no CT imaging performed. If CT imaging was systematically completed on these patients, additional cases of CT-only pneumonia would likely have been discovered. Third, patients were considered to have CT-only pneumonia if a CT scan showing evidence of pneumonia was completed on the same day or the day following a chest radiograph that showed no signs of pneumonia, and both imaging studies were completed within 2 days of hospital admission. Only including patients who had a CT scan obtained immediately after a chest radiograph (within minutes or hours) may have decreased the discordance between chest radiography and CT imaging; however, considering a CT scan and chest radiograph performed within 1 calendar day of each other as concurrent imaging is consistent with clinical practice in which routine chest imaging more frequently than once per day is not recommended.[@bib4] Fourth, multiple comparisons between groups were performed, and differences observed should be considered hypothesis generating. Fifth, although this is the largest study to date assessing clinical outcomes of patients with CT-only pneumonia, our sample size was somewhat limited, precluding multivariable analyses and robust comparisons of rare outcomes, such as mortality. Sixth, nearly all patients were treated with antibiotics; hence, the impact of antibiotics on clinical outcomes could not be evaluated. Finally, only hospitalized patients were included in this study, and generalizability to the outpatient setting is unknown.

Conclusions {#sec4}
===========

In this large prospective cohort study of adults hospitalized with CAP who underwent systematic testing for the cause of the pneumonia, patients with pneumonia visualized on CT scans but not on chest radiographs had pathogens and clinical outcomes similar to those of patients who had pneumonia visualized on chest radiographs. These findings support the management of patients with pneumonia visualized only on CT scans according to the same principles as those with pneumonia visualized on chest radiographs.

Supplementary Data {#appsec1}
==================

e-Tables 1-8 Audio
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[^1]: ATS = American Thoracic Society; CURB-65 = confusion, uremia, respiratory rate, blood pressure, age ≥ 65 years; IQR = interquartile range.

[^2]: Five hundred twenty patients did not have PCT measured, including 17 (25.8%) in the CT-only pneumonia group and 503 (23.0%) in the pneumonia seen on chest radiography group.

[^3]: Respiratory fluoroquinolones: gemifloxacin, levofloxacin, and moxifloxacin.

[^4]: Other bacteria included *Fusobacteria* (3 cases), *Enterobacter* (2 cases), *Neisseria, Bacteroides, Pasteurella,* and *Proteus*.

[^5]: See [Table 1](#tbl1){ref-type="table"} legend for expansion of abbreviation.
